'Ozone hole' , which cause a great increment of the UV radiation to the earth surface, is a exclusive phenomena over the Antarctic. After living in high UV radiation for a long time , plankton in the Antarctic have produced many anti-radiation active substances. In this article, the properties, configurations, functions, etc. of anti-radiation active substances in algae, bacteria and fungi in the Antarctic wen: summarized. At the same time, significative illuminations on the studies and utilization of anti-radiation and anti-tumour active substances are expected.

Ice microalgae, which inhabit in the extreme conditions of polar marine environment, not only play an important role in Antarctica ecosystem but also show broad prospects in basic research and application. Ice microalgae have the specific physiological and metabolic properties that are responsible for their adaptation and acclimation to the special polar conditions. Based on the references in the recent twenty years and the partial research results of author's, the ice microalgae composition and distribution, and the application in bait, unsaturated fatty acid, anti-freezing proteins, UV-absorbing pigments and other active substances are reviewed. It is expected to provide references for the research and active substance exploitations of ice microalgae.

Objective:To explore the long-term effects of intravascular ultrasound (IVUS) guidance on patients with acute coronary syndrome (ACS) undergoing drug-eluting stents (DES) implantation.Methods:Data used in this study derived from ULTIMATE trial, which was a prospective, multicenter, randomized study. A total of 1 448 all-comer patients were enrolled between 2014 August and 2017 May. Primary endpoint of this study was target vessel failure (TVF) at 3 years, including cardiac death, target-vessel-related myocardial infarction, and clinically-driven target vessel revascularization.Results:ACS was present in 1 136 (78.5%) patients, and 3-year clinical follow-up was available in 1 423 patients (98.3%). TVF in the ACS group was 9.6% (109/1 136), which was significantly higher than 4.5% (14/312) in the non-ACS group (log-rank P=0.005). There were 109 TVFs in the ACS patients, with 7.6% (43/569) TVFs in the IVUS group and 11.6% (66/567) TVFs in the angiography group (log-rank P=0.019). Moreover, patients with optimal IVUS guidance were associated with a lower risk of 3-year TVF compared to those with suboptimal IVUS results (5.4% (16/296) vs. 9.9% (27/273),log-rank P=0.041). Conclusions:This ULTIMATE-ACS subgroup analysis showed that ACS patients undergoing DES implantation were associated with a higher risk of 3-year TVF. More importantly, the risk of TVF could be significantly decreased through IVUS guidance in patients with ACS, especially in those who had an IVUS-defined optimal procedure.